SFS
TCRT icon

Sowell Financial Services’s Alaunos Therapeutics TCRT Stock Holding History

Sowell Financial Services’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1
Closed – – 3294
2020
Q4 		$0 Sell
1
-2
-67% -$795 ﹤0.01% 2855
2020
Q3 		$1K Hold
3
– – ﹤0.01% 2430
2020
Q2 		$1K Hold
3
– – ﹤0.01% 2369
2020
Q1 		$1K Hold
3
– – ﹤0.01% 2320
2019
Q4 		$2K Sell
3
-1
-25% -$688 ﹤0.01% 2241
2019
Q3 		$3K Buy
+4
New +$3.17K ﹤0.01% 1981

Other funds holding TCRT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Sowell Financial Services's TCRT Position: Q1 2021 in Review

Sowell Financial Services sold out of Alaunos Therapeutics (TCRT) in Q1 2021, closing a stake of 1 share.

Sowell Financial Services first reported a position in TCRT in Q3 2019 and held it in 6 quarters. The position peaked at $3K in Q3 2019. 150 funds tracked by Wall St. Rank hold TCRT as of Q1 2021.

  • Sowell Financial Services reported no remaining Alaunos Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1 Alaunos Therapeutics share in Q1 2021.
  • Sowell Financial Services first reported a position in Alaunos Therapeutics in Q3 2019 and held it in 6 quarters.
  • Sowell Financial Services's Alaunos Therapeutics position peaked at $3K in Q3 2019.
  • 150 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.